Study on Liposomal Irinotecan, TAS102, and Bevacizumab for Patients with Advanced Colorectal Cancer | Clinical Trial

Study on Liposomal Irinotecan, TAS102, and Bevacizumab for Patients with Advanced Colorectal Cancer | Clinical Trial | Right2Hope